Publication | Closed Access

Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 μg ethinyl estradiol and 2.00 mg dienogest on the hemostatic system

ContraceptionHormonal ContraceptiveMonophasic Oral ContraceptiveOral ContraceptiveMedicineReproductive HealthGynecologyHemostatic SystemPharmacotherapyμG Ethinyl EstradiolEndocrinologyPharmacologyWomen's Health